Find information on thousands of medical conditions and prescription drugs.

Terazosin

Terazosin (Hytrin) is an alpha blocker used for treatment of symptoms of prostate enlargement (BPH). It also acts to lower the blood pressure, so is a drug of choice for men with hypertension and prostate enlargement.

It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls.

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Oxytetracycline
Phentermine
Tacrine
Tacrolimus
Tagamet
Talbutal
Talohexal
Talwin
Tambocor
Tamiflu
Tamoxifen
Tamsulosin
Tao
Tarka
Taurine
Taxol
Taxotere
Tazarotene
Tazobactam
Tazorac
Tegretol
Teicoplanin
Telmisartan
Temazepam
Temocillin
Temodar
Temodar
Temozolomide
Tenex
Teniposide
Tenoretic
Tenormin
Tenuate
Terazosin
Terbinafine
Terbutaline
Terconazole
Terfenadine
Teriparatide
Terlipressin
Tessalon
Testosterone
Tetrabenazine
Tetracaine
Tetracycline
Tetramethrin
Thalidomide
Theo-24
Theobid
Theochron
Theoclear
Theolair
Theophyl
Theophyl
Theostat 80
Theovent
Thiamine
Thiomersal
Thiopental sodium
Thioridazine
Thorazine
Thyroglobulin
Tiagabine
Tianeptine
Tiazac
Ticarcillin
Ticlopidine
Tikosyn
Tiletamine
Timolol
Timoptic
Tinidazole
Tioconazole
Tirapazamine
Tizanidine
TobraDex
Tobramycin
Tofranil
Tolazamide
Tolazoline
Tolbutamide
Tolcapone
Tolnaftate
Tolterodine
Tomoxetine
Topamax
Topicort
Topiramate
Tora
Toradol
Toremifene
Tracleer
Tramadol
Trandate
Tranexamic acid
Tranxene
Tranylcypromine
Trastuzumab
Trazodone
Trenbolone
Trental
Trest
Tretinoin
Triacetin
Triad
Triamcinolone
Triamcinolone hexacetonide
Triamterene
Triazolam
Triclabendazole
Triclosan
Tricor
Trifluoperazine
Trilafon
Trileptal
Trimetazidine
Trimethoprim
Trimipramine
Trimox
Triprolidine
Triptorelin
Tritec
Trizivir
Troglitazone
Tromantadine
Trovafloxacin
Tubocurarine chloride
Tussionex
Tylenol
Tyrosine
U
V
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


Terazosin for benign prostatic hyperplasia and hypertension - includes editor comment - adapted from the Journal of Family Practice, August 1994 - Tips
From American Family Physician, 1/1/95 by Douglas B. Kamerow

Terazosin is an [alpha.sub.1] blocker that was first approved for use as an antihypertensive agent. It has recently received approval for use in the treatment of benign prostatic hyperplasia (BPH). Guthrie evaluated the effectiveness of terazosin in a population of men with both hypertension and BPH.

Of 5,365 middle-aged hypertensive men enrolled in the study, 1,483 had both essential hypertension and symptomatic BPH. Patients were given terazosin over a 12-week period in an open-label trial. Drug dosage was increased by protocol to obtain adequate antihypertensive response. The Boyarsky scale, a validated instrument for scoring symptoms related to BPH, was administered at the beginning and the end of the 12-week trial.

Significant reductions in mean systolic and diastolic blood pressures were noted after 12 weeks in all patients with hypertension. In addition, Boyarsky scores of BPH symptoms were reduced by an average of 55 percent in the 1,483 symptomatic men. Adverse side effects were mild.

The authors conclude that terazosin is a safe and effective treatment for patients with both hypertension and BPH. (Journal of Family Practice, August 1994, vol. 39, p. 129.)

EDITOR'S NOTE: This trial, although well-conducted by community primary care physicians on a large number of patients, was not a randomized, placebo-controlled trial. The placebo effect could have accounted for some (or even all) of the improvement in BPH symptoms in these men. As the authors observe, long-term, placebo-controlled trials are needed to validate these results and to determine whether terazosin treatment will help postpone or prevent the need for prostate surgery in patients with symptomatic BPH.

COPYRIGHT 1995 American Academy of Family Physicians
COPYRIGHT 2004 Gale Group

Return to Terazosin
Home Contact Resources Exchange Links ebay